Comparative in-vitro activity of moxifloxacin, minocycline and azithromycin against Chlamydia spp.

被引:71
作者
Donati, M [1 ]
Fermepin, MR [1 ]
Olmo, A [1 ]
D'Apote, L [1 ]
Cevenini, R [1 ]
机构
[1] Univ Bologna, Policlin S Orsola, DMCSS, Sez Microbiol, Bologna, Italy
关键词
D O I
10.1093/jac/43.6.825
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The in-vitro activity of moxifloxacin, a new 8-methoxyquinolone, was compared with minocycline and azithromycin against 40 strains of Chlamydia trachomatis, Chlamydia pneumoniae and Chlamydia psittaci. Both the MIC and the MBC of moxifloxacin ranged from 0.03 to 0.125 mg/L, MICs of minocycline ranged from 0.015 to 0.06 mg/L and MBCs between 0.03 and 0.25 mg/L. MICs of azithromycin ranged from 0.03 to 0.125 mg/L and the MBCs between 0.06 and 0.5 mg/L, MBC values of moxifloxacin were the same as MICs in 32 (80%) of 40 strains tested, whereas those of minocycline and azithromycin were two to four times higher than their MICs. These data confirm those previously obtained indicating that quinolones kill chlamydial strains at concentrations equivalent to their MICs.
引用
收藏
页码:825 / 827
页数:3
相关论文
共 10 条
[1]   In vitro activity of BAY 12-8039, a new fluoroquinolone, against mycoplasmas [J].
Bébéar, CM ;
Renaudin, H ;
Boudjadja, A ;
Bébéar, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (03) :703-704
[2]  
CEVENINI R, 1987, FEMS MICROBIOL LETT, V42, P47, DOI 10.1111/j.1574-6968.1987.tb02297.x
[3]   In vitro activity of BAY 12-8039, a new 8-methoxyquinolone [J].
Dalhoff, A ;
Petersen, U ;
Endermann, R .
CHEMOTHERAPY, 1996, 42 (06) :410-425
[4]   In vitro activity of Bay 12-8039, a new 8-methoxyquinolone [J].
Fass, RJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (08) :1818-1824
[5]   PREVALENCE IN HUMAN-BEINGS OF ANTIBODIES TO CHLAMYDIA IOL-207, AN ATYPICAL STRAIN OF CHLAMYDIA [J].
FORSEY, T ;
DAROUGAR, S ;
TREHARNE, JD .
JOURNAL OF INFECTION, 1986, 12 (02) :145-152
[6]   INVITRO ACTIVITIES OF 5 QUINOLONES AGAINST CHLAMYDIA-PNEUMONIAE [J].
HAMMERSCHLAG, MR ;
HYMAN, CL ;
ROBLIN, PM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (03) :682-683
[7]   In vitro and in vivo activities of AM-1155, a new fluoroquinolone, against Chlamydia spp. [J].
Miyashita, N ;
Niki, Y ;
Kishimoto, T ;
Nakajima, M ;
Matsushima, T .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (06) :1331-1334
[8]   Chlamydiae as pathogens: New species and new issues [J].
Peeling, RW ;
Brunham, RC .
EMERGING INFECTIOUS DISEASES, 1996, 2 (04) :307-319
[9]   In vitro activity of trovafloxacin against Chlamydia pneumoniae [J].
Roblin, PM ;
Kutlin, A ;
Hammerschlag, MR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (09) :2033-2034
[10]   In vitro activity of BAY 12-8039, a new fluoroquinolone [J].
Woodcock, JM ;
Andrews, JM ;
Boswell, FJ ;
Brenwald, NP ;
Wise, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (01) :101-106